First Hawaiian Bank’s Acorda Therapeutics ACOR Stock Holding History

First Hawaiian Bank’s Portfolio ACOR Stock Details ACOR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-6	Closed	-$11K	–	1861
2018 Q4	$11K	Buy	+6	New	+$13.1K	﹤0.01%	1447

Other funds holding ACOR

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SCM

Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

First Hawaiian Bank's ACOR Position: Q1 2019 in Review

First Hawaiian Bank sold out of Acorda Therapeutics (ACOR) in Q1 2019, closing a stake of 6 shares — an estimated $11K sold.

First Hawaiian Bank first reported a position in ACOR in Q4 2018 and held it in 1 quarter. The position peaked at $11K in Q4 2018. 184 funds tracked by Wall St. Rank hold ACOR as of Q1 2019.

First Hawaiian Bank reported no remaining Acorda Therapeutics position as of Q1 2019 after selling out during the quarter.
First Hawaiian Bank sold 6 Acorda Therapeutics shares in Q1 2019, an estimated $11K.
First Hawaiian Bank first reported a position in Acorda Therapeutics in Q4 2018 and held it in 1 quarter.
First Hawaiian Bank's Acorda Therapeutics position peaked at $11K in Q4 2018.
184 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q1 2019.

Based on First Hawaiian Bank's 13F filing for Q1 2019, filed 2 Apr 2019.